期刊文献+

尿激酶溶栓治疗心源性脑栓塞的临床研究 被引量:7

Chinical study on thormbolysis therapy with urokinase in treatment of cardiogenic cerebral embolism.
原文传递
导出
摘要 目的评价尿激酶(UK)溶栓治疗心源性脑栓塞的临床疗效及安全性。方法采用国产尿激酶100~150万U静脉滴注,对42例发病在6h以内的心源性脑栓塞患者进行溶栓治疗,比较治疗前后神经功能缺损评分(NFDI)。另设40例普通病例作对照组。结果溶栓后2hNFDI为20.12±2.65,较溶栓治疗前26.78±3.42明显减少(P<0.001),治疗后21d溶栓组NFDI为18.21±3.16,明显低于对照组,治疗后21d溶栓治疗组的治愈率、显效率、总有效率分别为33.3%、69%、88.1%,显著高于对照组(15%、32.5%、50%),两组比较有显著差异(P<0.05)。结论在严格掌握溶栓治疗适应症的基础上应用尿激酶静脉溶栓治疗心源性脑栓塞疗效好、并发症少。 Aim To evaluation the clinical effect and safety of thormbolysis therapy with urokinase in treatment of cardiogenic cerebral embolism. Methods Nerve function defect integral was compared in 42 patients before and after thrombolysis with urokinase 1 000-1 500KU intravenous drip within 6h after cardiogenic cerebral embohsm onset. Meanwhile another 40 cases with cardiogenic cerebral embolism treated with routine drugs were served as control. Results The NFDI examined 2h and 21 days after thrombolysis was markedly lower than that before thrombolysis(20.12±2.65,18.21±3.16 Vs 26.78±3.42,P〈0.001) and the control group. A remarkable difference was noticed between them. The cure rate,the effectual rate and the total effective rate evaluated 21 days after thrombolysis were all higher than those in control group (33.3% ,69%, 88.1% ,respectively.). Conclusions This study revealed that intravenous thrombolysis with urokinase in the treatment of cardiogenic cerebral embolism has a better clinical curative effect and less complication when the indications are strictly controlled.
出处 《中国热带医学》 CAS 2010年第10期1256-1257,共2页 China Tropical Medicine
关键词 尿激酶 心源性脑栓塞 溶栓治疗 Urokinase Cardiogenic cerebral embolism Thrombolysis therapy
  • 相关文献

参考文献5

二级参考文献19

  • 1The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med, 1995, 333(5): 1580-1587.
  • 2Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study(ECASS ).JAMA, 1995, 274 (5): 1017-1025.
  • 3Wardlaw JM, Warlow CP. Thrombolysis in acute ischemic stroke:does it work? Stroke, 1992, 23(12): 1826-1839
  • 4Mori E, Yoneda Y, Tabuchi M, et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology, 1992, 42(5): 976-982
  • 5Brott TG, Haley EC Jr, Levy DE, et al. Urgent therapy for stroke.Part Ⅱ. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke, 1992, 23(5): 632- 640
  • 6Trouillas P, Nighoghossian N, Getenet JC, et al. Open trial of intravenous tissue plasminogen activator in acute carotid territory stroke,Correlations of outcome with clinical and radiological data. Stroke.1996, 27(5): 882-890
  • 7Boysen G, Vorstrup S, Bogousslavsky J. Thrombolysis for stroketine for a consensus. Cerebrovasc Dis, 1996, 6(6): 376-380
  • 8The National Institute of Neurological Disorders and Stroke (NINDS) rt - PA Stroke Study Group. A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centers and implications for community practice and patient care. Stroke,1997, 28(8): 1530-1540
  • 9del Zopper GJ, Higashida RT, Furlah AJ, et al. PROACT: a phase Ⅱ randomized trial of recombinant Pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators.Prolyse in Acute Cerebral Thromboembolism. Stroke, 1998, 29(1 ):4-11.
  • 10Tomsick T, Brott T, Barsan W, et al. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultra early thrombolytic therapy. AJNR Am J Neuroradiol, 1996, 17(1):79-85.

共引文献42928

同被引文献40

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部